Vytorin researchers call for new data-release rules

Prompted by Merck and Schering-Plough's early release of the SEAS study data on Vytorin, Duke University researchers are calling for new rules governing the release of trial data; they'd invest third parties with more power to monitor research as it's going on and guard data once it's generated. Report [1]